Cancer Immunotherapy

The BioVox White Paper on Cancer Immunotherapy showcases innovators and world leaders in this exciting field, including GSK Biologicals, Janssen Immunosciences, Celyad, RXi Pharmaceuticals, eTheRNA, ImmunXperts, iTeos Therapeutics and PDC*line Pharma.

In this issue:

- Why is immunotherapy more than the latest hype?
- What are the challenges to bring lifesaving innovations to the patient?
- The price of life: who will pay for these treatments?
- Pioneering immunotherapy companies in the picture
- Insight in landmark oncology trials
- Academic innovations in immunotherapy


UGent Flanders.bio NLO V-Bio Ventures KU Leuven GSK Biowin Janssen Itera Life Science Turnstone

ABOUT BIOVOX - Sharing Life Sciences Innovations

BioVox showcases interesting life sciences breakthroughs for and from Belgian innovators. Through our partnership with BioCentury we share relevant worldwide innovations and business updates while our local journalists focus on regional highlights. 

Interested to get involved? Get in touch! We are looking for content, writers and partners! Blogs are available for research institutes, companies and freelance experts.

You want to reach out to the biotechnology and life sciences community, targetting selected audiences? Discover our sponsor and publication opportunities as well as tailored packages!

Contact BioVox via news@biovox.be or by completing the contact form.